At close: December 20 at 4:00:03 PM EST
After hours: December 20 at 6:08:50 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-25,749.0000
-11,980.0000
-22,686.0000
-28,504.0000
-8,943.0000
Investing Cash Flow
--
--
--
-15,000.0000
--
Financing Cash Flow
17,789.0000
-4,225.0000
729.0000
96,357.0000
23,895.0000
End Cash Position
33,853.0000
35,848.0000
52,153.0000
74,810.0000
21,967.0000
Interest Paid Supplemental Data
1,045.0000
1,778.0000
1,372.0000
559.0000
--
Capital Expenditure
--
--
--
-15,000.0000
--
Issuance of Capital Stock
27,789.0000
775.0000
699.0000
80,253.0000
24,907.0000
Issuance of Debt
--
--
--
14,951.0000
--
Repayment of Debt
-10,000.0000
-5,000.0000
--
--
--
Repurchase of Capital Stock
--
--
--
--
-1,012.0000
Free Cash Flow
-25,749.0000
-11,980.0000
-22,686.0000
-43,504.0000
-8,943.0000
12/31/2020 - 2/4/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
COYA Coya Therapeutics, Inc.
5.24
+1.55%
GANX Gain Therapeutics, Inc.
1.5600
-0.64%
ANVS Annovis Bio, Inc.
4.3700
-0.68%
TFFP TFF Pharmaceuticals, Inc.
0.0650
-60.05%
ACIU AC Immune SA
2.6800
-0.74%
CGEM Cullinan Therapeutics, Inc.
11.60
+5.94%
ANIX Anixa Biosciences, Inc.
2.6900
0.00%
ABOS Acumen Pharmaceuticals, Inc.
1.8500
+2.78%
THAR Tharimmune, Inc.
2.0700
-1.43%
AVXL Anavex Life Sciences Corp.
8.63
+1.89%